Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5300
-0.0100 ( -1.85% ) 0.0K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5300
Previous close
$0.5400
Volume
0.0K
Market cap
$84.34M
Day range
$0.5410 - $0.5420
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 62 | Nov 14, 2023 |
| 10-k/a | Quarterly Reports | 7 | Oct 30, 2023 |
| 4 | Insider transactions | 1 | Oct 27, 2023 |
| 4 | Insider transactions | 1 | Oct 25, 2023 |
| 3 | Insider transactions | 1 | Oct 24, 2023 |
| 3 | Insider transactions | 1 | Oct 24, 2023 |
| 4 | Insider transactions | 1 | Oct 19, 2023 |
| 8-k | 8K-related | 13 | Oct 11, 2023 |
| 8-k | 8K-related | 13 | Oct 10, 2023 |
| 8-k | 8K-related | 14 | Oct 10, 2023 |